Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Four Oxford scientists, including Professor Timothy Behrens of the Nuffield Department of Clinical Neurosciences, were honoured at the UK's inaugural Blavatnik Awards for Young Scientists ceremony, held at London's Victoria and Albert Museum.

The new awards celebrate the UK's most promising young faculty-level scientists and form part of the wider Blavatnik Awards programme, established by the Blavatnik Family Foundation and administered by the New York Academy of Sciences.

Professor Andrew Goodwin of the Department of Chemistry and Professor Henry Snaith of the Department of Physics were named laureates in chemistry and physical sciences & engineering respectively.

Also honoured at the ceremony were Professor Timothy Behrens of the Nuffield Department of Clinical Neurosciences and Professor Philipp Kukura of the Department of Chemistry, finalists in the life sciences and chemistry categories.

Find out more (University of Oxford website)

Similar stories

Oxford University wins prestigious Queen’s Anniversary Prize

Her Majesty The Queen has approved the award of The Queen’s Anniversary Prizes to twenty-one higher and further education institutions, including Oxford University, in the most recent round of the independently reviewed scheme. This prestigious award is the highest national honour available to universities and FE colleges across the UK.

Jenner Institute named Covid Innovation Heroes

The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award­ 2021.

Study reveals ‘stop-eating’ response to DNA damage

A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.